Global Musculoskeletal System Disorder Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: GF8812B939A6EN
QYResearch

Abstracts

This report focuses on the global Musculoskeletal System Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Musculoskeletal System Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AB Science
• AbGenomics International, Inc.
• Alder BioPharmaceuticals,Inc.
• Amgen Inc.
• Lexicon Pharmaceuticals, Inc.
• LG Chem
• OrthoTrophix, Inc.
• Tarsa Therapeutics, Inc.
• PhytoHealth Corporation
• Eisai Co., Ltd
• Astellas Pharma Inc.
• AstraZeneca
• Baxter
• GlaxoSmithKline PLC

Market segment by Type, the product can be split into

• Rheumatoid Arthritis
• Osteoarthritis
• Osteoporosis
• Others

Market segment by Application, split into

• Hospitals & Clinics
• Academic & Research Institutes

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Musculoskeletal System Disorder status, future forecast, growth opportunity, key market and key players.
• To present the Musculoskeletal System Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Musculoskeletal System Disorder are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Musculoskeletal System Disorder Revenue
1.4 Market Analysis by Type
  1.4.1 Global Musculoskeletal System Disorder Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Rheumatoid Arthritis
  1.4.3 Osteoarthritis
  1.4.4 Osteoporosis
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Musculoskeletal System Disorder Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals & Clinics
  1.5.3 Academic & Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Musculoskeletal System Disorder Industry Impact
  1.6.1 How the Covid-19 is Affecting the Musculoskeletal System Disorder Industry
    1.6.1.1 Musculoskeletal System Disorder Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Musculoskeletal System Disorder Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Musculoskeletal System Disorder Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Musculoskeletal System Disorder Market Perspective (2015-2026)
2.2 Musculoskeletal System Disorder Growth Trends by Regions
  2.2.1 Musculoskeletal System Disorder Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Musculoskeletal System Disorder Historic Market Share by Regions (2015-2020)
  2.2.3 Musculoskeletal System Disorder Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Musculoskeletal System Disorder Market Growth Strategy
  2.3.6 Primary Interviews with Key Musculoskeletal System Disorder Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Musculoskeletal System Disorder Players by Market Size
  3.1.1 Global Top Musculoskeletal System Disorder Players by Revenue (2015-2020)
  3.1.2 Global Musculoskeletal System Disorder Revenue Market Share by Players (2015-2020)
  3.1.3 Global Musculoskeletal System Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Musculoskeletal System Disorder Market Concentration Ratio
  3.2.1 Global Musculoskeletal System Disorder Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Musculoskeletal System Disorder Revenue in 2019
3.3 Musculoskeletal System Disorder Key Players Head office and Area Served
3.4 Key Players Musculoskeletal System Disorder Product Solution and Service
3.5 Date of Enter into Musculoskeletal System Disorder Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Musculoskeletal System Disorder Historic Market Size by Type (2015-2020)
4.2 Global Musculoskeletal System Disorder Forecasted Market Size by Type (2021-2026)

5 MUSCULOSKELETAL SYSTEM DISORDER BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Musculoskeletal System Disorder Market Size by Application (2015-2020)
5.2 Global Musculoskeletal System Disorder Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Musculoskeletal System Disorder Market Size (2015-2020)
6.2 Musculoskeletal System Disorder Key Players in North America (2019-2020)
6.3 North America Musculoskeletal System Disorder Market Size by Type (2015-2020)
6.4 North America Musculoskeletal System Disorder Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Musculoskeletal System Disorder Market Size (2015-2020)
7.2 Musculoskeletal System Disorder Key Players in Europe (2019-2020)
7.3 Europe Musculoskeletal System Disorder Market Size by Type (2015-2020)
7.4 Europe Musculoskeletal System Disorder Market Size by Application (2015-2020)

8 CHINA

8.1 China Musculoskeletal System Disorder Market Size (2015-2020)
8.2 Musculoskeletal System Disorder Key Players in China (2019-2020)
8.3 China Musculoskeletal System Disorder Market Size by Type (2015-2020)
8.4 China Musculoskeletal System Disorder Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Musculoskeletal System Disorder Market Size (2015-2020)
9.2 Musculoskeletal System Disorder Key Players in Japan (2019-2020)
9.3 Japan Musculoskeletal System Disorder Market Size by Type (2015-2020)
9.4 Japan Musculoskeletal System Disorder Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Musculoskeletal System Disorder Market Size (2015-2020)
10.2 Musculoskeletal System Disorder Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Musculoskeletal System Disorder Market Size by Type (2015-2020)
10.4 Southeast Asia Musculoskeletal System Disorder Market Size by Application (2015-2020)

11 INDIA

11.1 India Musculoskeletal System Disorder Market Size (2015-2020)
11.2 Musculoskeletal System Disorder Key Players in India (2019-2020)
11.3 India Musculoskeletal System Disorder Market Size by Type (2015-2020)
11.4 India Musculoskeletal System Disorder Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Musculoskeletal System Disorder Market Size (2015-2020)
12.2 Musculoskeletal System Disorder Key Players in Central & South America (2019-2020)
12.3 Central & South America Musculoskeletal System Disorder Market Size by Type (2015-2020)
12.4 Central & South America Musculoskeletal System Disorder Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AB Science
  13.1.1 AB Science Company Details
  13.1.2 AB Science Business Overview and Its Total Revenue
  13.1.3 AB Science Musculoskeletal System Disorder Introduction
  13.1.4 AB Science Revenue in Musculoskeletal System Disorder Business (2015-2020))
  13.1.5 AB Science Recent Development
13.2 AbGenomics International, Inc.
  13.2.1 AbGenomics International, Inc. Company Details
  13.2.2 AbGenomics International, Inc. Business Overview and Its Total Revenue
  13.2.3 AbGenomics International, Inc. Musculoskeletal System Disorder Introduction
  13.2.4 AbGenomics International, Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020)
  13.2.5 AbGenomics International, Inc. Recent Development
13.3 Alder BioPharmaceuticals,Inc.
  13.3.1 Alder BioPharmaceuticals,Inc. Company Details
  13.3.2 Alder BioPharmaceuticals,Inc. Business Overview and Its Total Revenue
  13.3.3 Alder BioPharmaceuticals,Inc. Musculoskeletal System Disorder Introduction
  13.3.4 Alder BioPharmaceuticals,Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020)
  13.3.5 Alder BioPharmaceuticals,Inc. Recent Development
13.4 Amgen Inc.
  13.4.1 Amgen Inc. Company Details
  13.4.2 Amgen Inc. Business Overview and Its Total Revenue
  13.4.3 Amgen Inc. Musculoskeletal System Disorder Introduction
  13.4.4 Amgen Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020)
  13.4.5 Amgen Inc. Recent Development
13.5 Lexicon Pharmaceuticals, Inc.
  13.5.1 Lexicon Pharmaceuticals, Inc. Company Details
  13.5.2 Lexicon Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.5.3 Lexicon Pharmaceuticals, Inc. Musculoskeletal System Disorder Introduction
  13.5.4 Lexicon Pharmaceuticals, Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020)
  13.5.5 Lexicon Pharmaceuticals, Inc. Recent Development
13.6 LG Chem
  13.6.1 LG Chem Company Details
  13.6.2 LG Chem Business Overview and Its Total Revenue
  13.6.3 LG Chem Musculoskeletal System Disorder Introduction
  13.6.4 LG Chem Revenue in Musculoskeletal System Disorder Business (2015-2020)
  13.6.5 LG Chem Recent Development
13.7 OrthoTrophix, Inc.
  13.7.1 OrthoTrophix, Inc. Company Details
  13.7.2 OrthoTrophix, Inc. Business Overview and Its Total Revenue
  13.7.3 OrthoTrophix, Inc. Musculoskeletal System Disorder Introduction
  13.7.4 OrthoTrophix, Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020)
  13.7.5 OrthoTrophix, Inc. Recent Development
13.8 Tarsa Therapeutics, Inc.
  13.8.1 Tarsa Therapeutics, Inc. Company Details
  13.8.2 Tarsa Therapeutics, Inc. Business Overview and Its Total Revenue
  13.8.3 Tarsa Therapeutics, Inc. Musculoskeletal System Disorder Introduction
  13.8.4 Tarsa Therapeutics, Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020)
  13.8.5 Tarsa Therapeutics, Inc. Recent Development
13.9 PhytoHealth Corporation
  13.9.1 PhytoHealth Corporation Company Details
  13.9.2 PhytoHealth Corporation Business Overview and Its Total Revenue
  13.9.3 PhytoHealth Corporation Musculoskeletal System Disorder Introduction
  13.9.4 PhytoHealth Corporation Revenue in Musculoskeletal System Disorder Business (2015-2020)
  13.9.5 PhytoHealth Corporation Recent Development
13.10 Eisai Co., Ltd
  13.10.1 Eisai Co., Ltd Company Details
  13.10.2 Eisai Co., Ltd Business Overview and Its Total Revenue
  13.10.3 Eisai Co., Ltd Musculoskeletal System Disorder Introduction
  13.10.4 Eisai Co., Ltd Revenue in Musculoskeletal System Disorder Business (2015-2020)
  13.10.5 Eisai Co., Ltd Recent Development
13.11 Astellas Pharma Inc.
  10.11.1 Astellas Pharma Inc. Company Details
  10.11.2 Astellas Pharma Inc. Business Overview and Its Total Revenue
  10.11.3 Astellas Pharma Inc. Musculoskeletal System Disorder Introduction
  10.11.4 Astellas Pharma Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020)
  10.11.5 Astellas Pharma Inc. Recent Development
13.12 AstraZeneca
  10.12.1 AstraZeneca Company Details
  10.12.2 AstraZeneca Business Overview and Its Total Revenue
  10.12.3 AstraZeneca Musculoskeletal System Disorder Introduction
  10.12.4 AstraZeneca Revenue in Musculoskeletal System Disorder Business (2015-2020)
  10.12.5 AstraZeneca Recent Development
13.13 Baxter
  10.13.1 Baxter Company Details
  10.13.2 Baxter Business Overview and Its Total Revenue
  10.13.3 Baxter Musculoskeletal System Disorder Introduction
  10.13.4 Baxter Revenue in Musculoskeletal System Disorder Business (2015-2020)
  10.13.5 Baxter Recent Development
13.14 GlaxoSmithKline PLC
  10.14.1 GlaxoSmithKline PLC Company Details
  10.14.2 GlaxoSmithKline PLC Business Overview and Its Total Revenue
  10.14.3 GlaxoSmithKline PLC Musculoskeletal System Disorder Introduction
  10.14.4 GlaxoSmithKline PLC Revenue in Musculoskeletal System Disorder Business (2015-2020)
  10.14.5 GlaxoSmithKline PLC Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Musculoskeletal System Disorder Key Market Segments
Table 2. Key Players Covered: Ranking by Musculoskeletal System Disorder Revenue
Table 3. Ranking of Global Top Musculoskeletal System Disorder Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Musculoskeletal System Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rheumatoid Arthritis
Table 6. Key Players of Osteoarthritis
Table 7. Key Players of Osteoporosis
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Musculoskeletal System Disorder Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Musculoskeletal System Disorder Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Musculoskeletal System Disorder Players to Combat Covid-19 Impact
Table 14. Global Musculoskeletal System Disorder Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Musculoskeletal System Disorder Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Musculoskeletal System Disorder Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Musculoskeletal System Disorder Market Share by Regions (2015-2020)
Table 18. Global Musculoskeletal System Disorder Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Musculoskeletal System Disorder Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Musculoskeletal System Disorder Market Growth Strategy
Table 24. Main Points Interviewed from Key Musculoskeletal System Disorder Players
Table 25. Global Musculoskeletal System Disorder Revenue by Players (2015-2020) (Million US$)
Table 26. Global Musculoskeletal System Disorder Market Share by Players (2015-2020)
Table 27. Global Top Musculoskeletal System Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal System Disorder as of 2019)
Table 28. Global Musculoskeletal System Disorder by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Musculoskeletal System Disorder Product Solution and Service
Table 31. Date of Enter into Musculoskeletal System Disorder Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Musculoskeletal System Disorder Market Size by Type (2015-2020) (Million US$)
Table 34. Global Musculoskeletal System Disorder Market Size Share by Type (2015-2020)
Table 35. Global Musculoskeletal System Disorder Revenue Market Share by Type (2021-2026)
Table 36. Global Musculoskeletal System Disorder Market Size Share by Application (2015-2020)
Table 37. Global Musculoskeletal System Disorder Market Size by Application (2015-2020) (Million US$)
Table 38. Global Musculoskeletal System Disorder Market Size Share by Application (2021-2026)
Table 39. North America Key Players Musculoskeletal System Disorder Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Musculoskeletal System Disorder Market Share (2019-2020)
Table 41. North America Musculoskeletal System Disorder Market Size by Type (2015-2020) (Million US$)
Table 42. North America Musculoskeletal System Disorder Market Share by Type (2015-2020)
Table 43. North America Musculoskeletal System Disorder Market Size by Application (2015-2020) (Million US$)
Table 44. North America Musculoskeletal System Disorder Market Share by Application (2015-2020)
Table 45. Europe Key Players Musculoskeletal System Disorder Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Musculoskeletal System Disorder Market Share (2019-2020)
Table 47. Europe Musculoskeletal System Disorder Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Musculoskeletal System Disorder Market Share by Type (2015-2020)
Table 49. Europe Musculoskeletal System Disorder Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Musculoskeletal System Disorder Market Share by Application (2015-2020)
Table 51. China Key Players Musculoskeletal System Disorder Revenue (2019-2020) (Million US$)
Table 52. China Key Players Musculoskeletal System Disorder Market Share (2019-2020)
Table 53. China Musculoskeletal System Disorder Market Size by Type (2015-2020) (Million US$)
Table 54. China Musculoskeletal System Disorder Market Share by Type (2015-2020)
Table 55. China Musculoskeletal System Disorder Market Size by Application (2015-2020) (Million US$)
Table 56. China Musculoskeletal System Disorder Market Share by Application (2015-2020)
Table 57. Japan Key Players Musculoskeletal System Disorder Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Musculoskeletal System Disorder Market Share (2019-2020)
Table 59. Japan Musculoskeletal System Disorder Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Musculoskeletal System Disorder Market Share by Type (2015-2020)
Table 61. Japan Musculoskeletal System Disorder Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Musculoskeletal System Disorder Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Musculoskeletal System Disorder Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Musculoskeletal System Disorder Market Share (2019-2020)
Table 65. Southeast Asia Musculoskeletal System Disorder Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Musculoskeletal System Disorder Market Share by Type (2015-2020)
Table 67. Southeast Asia Musculoskeletal System Disorder Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Musculoskeletal System Disorder Market Share by Application (2015-2020)
Table 69. India Key Players Musculoskeletal System Disorder Revenue (2019-2020) (Million US$)
Table 70. India Key Players Musculoskeletal System Disorder Market Share (2019-2020)
Table 71. India Musculoskeletal System Disorder Market Size by Type (2015-2020) (Million US$)
Table 72. India Musculoskeletal System Disorder Market Share by Type (2015-2020)
Table 73. India Musculoskeletal System Disorder Market Size by Application (2015-2020) (Million US$)
Table 74. India Musculoskeletal System Disorder Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Musculoskeletal System Disorder Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Musculoskeletal System Disorder Market Share (2019-2020)
Table 77. Central & South America Musculoskeletal System Disorder Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Musculoskeletal System Disorder Market Share by Type (2015-2020)
Table 79. Central & South America Musculoskeletal System Disorder Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Musculoskeletal System Disorder Market Share by Application (2015-2020)
Table 81. AB Science Company Details
Table 82. AB Science Business Overview
Table 83. AB Science Product
Table 84. AB Science Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 85. AB Science Recent Development
Table 86. AbGenomics International, Inc. Company Details
Table 87. AbGenomics International, Inc. Business Overview
Table 88. AbGenomics International, Inc. Product
Table 89. AbGenomics International, Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 90. AbGenomics International, Inc. Recent Development
Table 91. Alder BioPharmaceuticals,Inc. Company Details
Table 92. Alder BioPharmaceuticals,Inc. Business Overview
Table 93. Alder BioPharmaceuticals,Inc. Product
Table 94. Alder BioPharmaceuticals,Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 95. Alder BioPharmaceuticals,Inc. Recent Development
Table 96. Amgen Inc. Company Details
Table 97. Amgen Inc. Business Overview
Table 98. Amgen Inc. Product
Table 99. Amgen Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 100. Amgen Inc. Recent Development
Table 101. Lexicon Pharmaceuticals, Inc. Company Details
Table 102. Lexicon Pharmaceuticals, Inc. Business Overview
Table 103. Lexicon Pharmaceuticals, Inc. Product
Table 104. Lexicon Pharmaceuticals, Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 105. Lexicon Pharmaceuticals, Inc. Recent Development
Table 106. LG Chem Company Details
Table 107. LG Chem Business Overview
Table 108. LG Chem Product
Table 109. LG Chem Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 110. LG Chem Recent Development
Table 111. OrthoTrophix, Inc. Company Details
Table 112. OrthoTrophix, Inc. Business Overview
Table 113. OrthoTrophix, Inc. Product
Table 114. OrthoTrophix, Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 115. OrthoTrophix, Inc. Recent Development
Table 116. Tarsa Therapeutics, Inc. Business Overview
Table 117. Tarsa Therapeutics, Inc. Product
Table 118. Tarsa Therapeutics, Inc. Company Details
Table 119. Tarsa Therapeutics, Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 120. Tarsa Therapeutics, Inc. Recent Development
Table 121. PhytoHealth Corporation Company Details
Table 122. PhytoHealth Corporation Business Overview
Table 123. PhytoHealth Corporation Product
Table 124. PhytoHealth Corporation Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 125. PhytoHealth Corporation Recent Development
Table 126. Eisai Co., Ltd Company Details
Table 127. Eisai Co., Ltd Business Overview
Table 128. Eisai Co., Ltd Product
Table 129. Eisai Co., Ltd Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 130. Eisai Co., Ltd Recent Development
Table 131. Astellas Pharma Inc. Company Details
Table 132. Astellas Pharma Inc. Business Overview
Table 133. Astellas Pharma Inc. Product
Table 134. Astellas Pharma Inc. Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 135. Astellas Pharma Inc. Recent Development
Table 136. AstraZeneca Company Details
Table 137. AstraZeneca Business Overview
Table 138. AstraZeneca Product
Table 139. AstraZeneca Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 140. AstraZeneca Recent Development
Table 141. Baxter Company Details
Table 142. Baxter Business Overview
Table 143. Baxter Product
Table 144. Baxter Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 145. Baxter Recent Development
Table 146. GlaxoSmithKline PLC Company Details
Table 147. GlaxoSmithKline PLC Business Overview
Table 148. GlaxoSmithKline PLC Product
Table 149. GlaxoSmithKline PLC Revenue in Musculoskeletal System Disorder Business (2015-2020) (Million US$)
Table 150. GlaxoSmithKline PLC Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Musculoskeletal System Disorder Market Share by Type: 2020 VS 2026
Figure 2. Rheumatoid Arthritis Features
Figure 3. Osteoarthritis Features
Figure 4. Osteoporosis Features
Figure 5. Others Features
Figure 6. Global Musculoskeletal System Disorder Market Share by Application: 2020 VS 2026
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Academic & Research Institutes Case Studies
Figure 9. Musculoskeletal System Disorder Report Years Considered
Figure 10. Global Musculoskeletal System Disorder Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Musculoskeletal System Disorder Market Share by Regions: 2020 VS 2026
Figure 12. Global Musculoskeletal System Disorder Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Musculoskeletal System Disorder Market Share by Players in 2019
Figure 15. Global Top Musculoskeletal System Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal System Disorder as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Musculoskeletal System Disorder Revenue in 2019
Figure 17. North America Musculoskeletal System Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Musculoskeletal System Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Musculoskeletal System Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Musculoskeletal System Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Musculoskeletal System Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Musculoskeletal System Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Musculoskeletal System Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. AB Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. AB Science Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 26. AbGenomics International, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. AbGenomics International, Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 28. Alder BioPharmaceuticals,Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Alder BioPharmaceuticals,Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 30. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Amgen Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 32. Lexicon Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Lexicon Pharmaceuticals, Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 34. LG Chem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. LG Chem Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 36. OrthoTrophix, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. OrthoTrophix, Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 38. Tarsa Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Tarsa Therapeutics, Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 40. PhytoHealth Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. PhytoHealth Corporation Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 42. Eisai Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Eisai Co., Ltd Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 44. Astellas Pharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Astellas Pharma Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 46. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. AstraZeneca Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 48. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Baxter Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 50. GlaxoSmithKline PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GlaxoSmithKline PLC Revenue Growth Rate in Musculoskeletal System Disorder Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed